Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Mapping EORTC-QLQ-C30 and QLQ-CR29 onto EQ-5D-5L in Colorectal Cancer Patients.

Ameri H, Yousefi M, Yaseri M, Nahvijou A, Arab M, Akbari Sari A.

J Gastrointest Cancer. 2019 Apr 12. doi: 10.1007/s12029-019-00229-6. [Epub ahead of print]

PMID:
30977049
2.

Cancer incidence in the East Azerbaijan province of Iran in 2015-2016: results of a population-based cancer registry.

Somi MH, Dolatkhah R, Sepahi S, Belalzadeh M, Sharbafi J, Abdollahi L, Nahvijou A, Nemati S, Malekzadeh R, Zendehdel K.

BMC Public Health. 2018 Nov 19;18(1):1266. doi: 10.1186/s12889-018-6119-9.

3.

The economic burden of oral cancer in Iran.

Rezapour A, Jahangiri R, Olyaeemanesh A, Kalaghchi B, Nouhi M, Nahvijou A.

PLoS One. 2018 Sep 27;13(9):e0203059. doi: 10.1371/journal.pone.0203059. eCollection 2018.

4.

Mapping the cancer-specific QLQ-C30 onto the generic EQ-5D-5L and SF-6D in colorectal cancer patients.

Ameri H, Yousefi M, Yaseri M, Nahvijou A, Arab M, Akbari Sari A.

Expert Rev Pharmacoecon Outcomes Res. 2019 Feb;19(1):89-96. doi: 10.1080/14737167.2018.1517046. Epub 2018 Sep 3.

PMID:
30173585
5.

Development of a tool for comprehensive evaluation of population-based cancer registries.

Sheikhtaheri A, Nahvijou A, Sedighi Z, Hadji M, Golmahi M, Roshandel G, Beiki O, Ravankhah Z, Zendehdel K.

Int J Med Inform. 2018 Sep;117:26-32. doi: 10.1016/j.ijmedinf.2018.06.006. Epub 2018 Jun 10.

PMID:
30032962
6.

Economic burden of colorectal cancer in Iran in 2012.

Vahdatimanesh Z, Zendehdel K, Kbari Sari AA, Farhan F, Nahvijou A, Delavari A, Daroudi R.

Med J Islam Repub Iran. 2017 Dec 20;31:115. doi: 10.14196/mjiri.31.115. eCollection 2017.

7.

Application of E75 peptide vaccine in breast cancer patients: A systematic review and meta-analysis.

Chamani R, Ranji P, Hadji M, Nahvijou A, Esmati E, Alizadeh AM.

Eur J Pharmacol. 2018 Jul 15;831:87-93. doi: 10.1016/j.ejphar.2018.05.010. Epub 2018 May 9. Review.

PMID:
29753042
8.

Systematic Review of Hospital Based Cancer Registries (HBCRs): Necessary Tool to Improve Quality of Care in Cancer Patients

Mohammadzadeh Z, Ghazisaeedi M, Nahvijou A, Rostam Niakan Kalhori S, Davoodi S, Zendehdel K.

Asian Pac J Cancer Prev. 2017 Aug 27;18(8):2027-2033.

9.

Serum Antibodies against Helicobacter pylori Neutrophil Activating Protein in Carriers of IL-4 C-590T Genetic Polymorphism Amplify the Risk of Gastritis and Gastric Cancer.

Talebkhan Y, Doozbakhshan M, Saberi S, Esmaeili M, Karami N, Mohajerani N, Abdirad A, Eshagh Hosseini M, Nahvijou A, Mohagheghi MA, Mohammadi M.

Iran Biomed J. 2017 Sep;21(5):321-9. Epub 2016 Sep 28.

10.

Cost-Effectiveness of Different Cervical Screening Strategies in Islamic Republic of Iran: A Middle-Income Country with a Low Incidence Rate of Cervical Cancer.

Nahvijou A, Daroudi R, Tahmasebi M, Amouzegar Hashemi F, Rezaei Hemami M, Akbari Sari A, Barati Marenani A, Zendehdel K.

PLoS One. 2016 Jun 8;11(6):e0156705. doi: 10.1371/journal.pone.0156705. eCollection 2016.

11.

Age-Specific Gastric Cancer Risk Indicated by the Combination of Helicobacter pylori Sero-Status and Serum Pepsinogen Levels.

Eybpoosh S, Talebkhan Y, Saberi S, Esmaeili M, Oghalaie A, Ebrahimzadeh F, Karimi T, Abdirad A, Nahvijou A, Mohagheghi MA, Eshagh Hosseini M, Mohammadi M.

Version 2. Iran Biomed J. 2015 Jul [revised 2009 Jan 1];19(3):133-42. Epub 2015 Jun 28.

12.

The Economic Burden of Breast Cancer in Iran.

Daroudi R, Akbari Sari A, Nahvijou A, Kalaghchi B, Najafi M, Zendehdel K.

Iran J Public Health. 2015 Sep;44(9):1225-33.

13.

Relationship between Spiritual Health and Quality of Life in Patients with Cancer.

Mohebbifar R, Pakpour AH, Nahvijou A, Sadeghi A.

Asian Pac J Cancer Prev. 2015;16(16):7321-6.

14.

Priority Setting for Improvement of Cervical Cancer Prevention in Iran.

Majidi A, Ghiasvand R, Hadji M, Nahvijou A, Mousavi AS, Pakgohar M, Khodakarami N, Abedini M, Amouzegar Hashemi F, Rahnamaye Farzami M, Shahsiah R, Sajedinejhad S, Mohagheghi MA, Nadali F, Rashidian A, Weiderpass E, Mogensen O, Zendehdel K.

Int J Health Policy Manag. 2015 Nov 22;5(4):225-32. doi: 10.15171/ijhpm.2015.201.

15.

A systematic review of economic aspects of cervical cancer screening strategies worldwide: discrepancy between economic analysis and policymaking.

Nahvijou A, Hadji M, Marnani AB, Tourang F, Bayat N, Weiderpass E, Daroudi R, Sari AA, Zendehdel K.

Asian Pac J Cancer Prev. 2014;15(19):8229-37. Review.

16.

Management of precancerous cervical lesions in iran: a cost minimizing study.

Nahvijou A, Sari AA, Zendehdel K, Marnani AB.

Asian Pac J Cancer Prev. 2014;15(19):8209-13.

17.

Challenges to promoting population-based cancer registration in Iran: a workshop report.

Hadji M, Nahvijou A, Seddighi Z, Beiki O, Mohagheghi MA, Mosavi-Jarrahi A, Marnani AB, Zendehdel K.

Asian Pac J Cancer Prev. 2013;14(10):6189-93.

18.

Six-fold difference in the stomach cancer mortality rate between northern and southern Iran.

Zendehdel K, Marzban M, Nahvijou A, Jafari N.

Arch Iran Med. 2012 Dec;15(12):741-6. doi: 0121512/AIM.004.

19.

Outcome of breast cancer in Iran: a study of Tehran Cancer Registry data.

Mousavi SM, Mohagheghi MA, Mousavi-Jerrahi A, Nahvijou A, Seddighi Z.

Asian Pac J Cancer Prev. 2008 Apr-Jun;9(2):275-8.

20.

Epstein-Barr virus associated gastric carcinoma: a report from Iran in the last four decades.

Abdirad A, Ghaderi-Sohi S, Shuyama K, Koriyama C, Nadimi-Barforoosh H, Emami S, Mosavi-Jarrahi A, Nahvijou A, Akiba S.

Diagn Pathol. 2007 Jul 15;2:25.

21.

Burden of breast cancer in Iran: a study of the Tehran population based cancer registry.

Mousavi SM, Mohaghegghi MA, Mousavi-Jerrahi A, Nahvijou A, Seddighi Z.

Asian Pac J Cancer Prev. 2006 Oct-Dec;7(4):571-4.

Supplemental Content

Loading ...
Support Center